Publication | Closed Access
Comprehensive molecular phenotyping of<i>ARID1A</i>-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities
28
Citations
54
References
2023
Year
Our results suggest a therapeutic strategy for <i>ARID1A</i>-mutated GCs targeting both tumour-intrinsic (BRD4-assocatiated promoter activation) and extrinsic (NFKB immunomodulation) cancer phenotypes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1